Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,738031,Alc14,Alcohol consumption QTL 14,7.6,0.00003,consumption behavior trait (VT:0002069),ethanol drink intake rate to body weight ratio (CMO:0001616),4,58640017,154427984,Rat,n/a,region,qtl 1000,738016,Alc16,Alcohol consumption QTL 16,3.6,0.00015,consumption behavior trait (VT:0002069),ethanol drink intake rate to body weight ratio (CMO:0001616),4,58640017,154427984,Rat,n/a,region,qtl 1000,70200,Alc18,Alcohol consumption QTL 18,9.2,,drinking behavior trait (VT:0001422),ethanol intake volume to total fluid intake volume ratio (CMO:0001591),4,55324953,148360954,Rat,n/a,region,qtl 1000,634335,Anxrr16,Anxiety related response QTL 16,7.22,,locomotor behavior trait (VT:0001392),number of entries into a discrete space in an experimental apparatus (CMO:0000960),4,94893247,168046938,Rat,n/a,region,qtl 1000,6478760,Anxrr45,Anxiety related response QTL 45,,0.06717,locomotor behavior trait (VT:0001392),amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958),4,110702761,155702761,Rat,n/a,region,qtl 1000,6478763,Anxrr46,Anxiety related response QTL 46,,0.07428,locomotor behavior trait (VT:0001392),amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958),4,110702761,155702761,Rat,n/a,region,qtl 1000,6478778,Anxrr51,Anxiety related response QTL 51,,0.25384,locomotor behavior trait (VT:0001392),"measurement of voluntary locomotion into, out of or within a discrete space in an experimental apparatus (CMO:0000957)",4,123587009,168587009,Rat,n/a,region,qtl 1000,12798519,Anxrr54,Anxiety related response QTL 54,2.54,0.05,locomotor behavior trait (VT:0001392),"distance moved per unit of time into, out of or within a discrete space in an experimental apparatus (CMO:0001493)",4,112807675,157807675,Rat,n/a,region,qtl 1000,12798523,Anxrr56,Anxiety related response QTL 56,2.83,0.05,locomotor behavior trait (VT:0001392),amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958),4,86312589,147702403,Rat,n/a,region,qtl 1000,12798527,Anxrr58,Anxiety related response QTL 58,4.11,0.05,locomotor behavior trait (VT:0001392),"distance moved per unit of time into, out of or within a discrete space in an experimental apparatus (CMO:0001493)",4,120318422,146087100,Rat,n/a,region,qtl 1000,1600376,Arunc5,Aerobic running capacity QTL 5,,0.21,exercise endurance trait (VT:0002332),maximum distance run on treadmill (CMO:0001406),3,78700444,123700444,Rat,n/a,region,qtl 1000,1578674,Bmd12,Bone mineral density QTL 12,3.8,,femur mineral mass (VT:0010011),cortical volumetric bone mineral density (CMO:0001730),4,137171018,182171018,Rat,n/a,region,qtl 1000,2293659,Bmd35,Bone mineral density QTL 35,4.5,0.0001,femur strength trait (VT:0010010),femoral neck ultimate force (CMO:0001703),4,136908430,182878540,Rat,n/a,region,qtl 1000,631683,Bp116,Blood pressure QTL 116,,0.0001,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),4,123111827,168111827,Rat,n/a,region,qtl 1000,631649,Bp123,Blood pressure QTL 123,3.2,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),3,94788365,139788365,Rat,n/a,region,qtl 1000,1331738,Bp209,Blood pressure QTL 209,2.979,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),4,136351734,180689124,Rat,n/a,region,qtl 1000,1358885,Bp251,Blood pressure QTL 251,3.8,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),3,10639528,127023997,Rat,n/a,region,qtl 1000,1358888,Bp264,Blood pressure QTL 264,4.43,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),3,10639528,127023997,Rat,n/a,region,qtl 1000,2303168,Bp330,Blood pressure QTL 330,4.25,0.017,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),4,3043231,145254791,Rat,n/a,region,qtl 1000,10755501,Bp390,Blood pressure QTL 390,2.5,,arterial blood pressure trait (VT:2000000),diastolic blood pressure (CMO:0000005),4,23850384,169318094,Rat,n/a,region,qtl 1000,7207480,Bss105,Bone structure and strength QTL 105,8.1,,femur strength trait (VT:0010010),femur midshaft polar moment of inertia (CMO:0001669),4,109636356,154636356,Rat,n/a,region,qtl 1000,1549832,Bss3,Bone structure and strength QTL 3,11,,femur morphology trait (VT:0000559),femur midshaft cortical cross-sectional area (CMO:0001663),4,109636356,154636356,Rat,n/a,region,qtl 1000,7387306,Bw124,Body weight QTL 124,3.2,0.0003,body mass (VT:0001259),body weight (CMO:0000012),3,88910015,133910015,Rat,n/a,region,qtl 1000,7411558,Bw133,Body weight QTL 133,13.84,0.001,body mass (VT:0001259),body weight gain (CMO:0000420),4,124442168,169442168,Rat,n/a,region,qtl 1000,8694437,Bw167,Body weight QTL 167,22.46,0.001,retroperitoneal fat pad mass (VT:0010430),retroperitoneal fat pad weight to body weight ratio (CMO:0000635),3,97009185,142009185,Rat,n/a,region,qtl 1000,12879848,Bw181,Body weght QTL 181,,0.015,body mass (VT:0001259),body weight (CMO:0000012),3,72672290,127023997,Rat,n/a,region,qtl 1000,1582219,Bw63,Body weight QTL 63,3.8,0.001,body mass (VT:0001259),body weight (CMO:0000012),3,100730984,119830094,Rat,n/a,region,qtl 1000,1582216,Bw65,Body weight QTL 65,6.3,,body mass (VT:0001259),body weight (CMO:0000012),3,106900427,119830094,Rat,n/a,region,qtl 1000,1582238,Bw68,Body weight QTL 68,3.2,0.0064,body mass (VT:0001259),body weight (CMO:0000012),3,54630948,119830094,Rat,n/a,region,qtl 1000,1582210,Bw71,Body weight QTL 71,3.3,0.0012,body mass (VT:0001259),body weight (CMO:0000012),3,66711607,119830094,Rat,n/a,region,qtl 1000,1582218,Bw74,Body weight QTL 74,3.9,0.0021,body mass (VT:0001259),body weight (CMO:0000012),3,54630948,119830094,Rat,n/a,region,qtl 1000,631665,Bw8,Body weight QTL 8,5.5,,body mass (VT:0001259),body weight (CMO:0000012),3,51821836,124513579,Rat,n/a,region,qtl 1000,2301970,Bw81,Body weight QTL 81,5.19,,body mass (VT:0001259),body weight (CMO:0000012),3,43295930,163640485,Rat,n/a,region,qtl 1000,2312670,Bw94,Body weight QTL 94,,0.01,inguinal fat pad mass (VT:0010424),inguinal fat pad weight to body weight ratio (CMO:0001253),3,103141814,176418101,Rat,n/a,region,qtl 1000,61422,Cia13,Collagen induced arthritis QTL 13,4.5,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),4,132455408,168047091,Rat,n/a,region,qtl 1000,61434,Cia3,Collagen induced arthritis QTL 3,4.8,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),4,99066823,144066823,Rat,n/a,region,qtl 1000,61451,Ciaa4,CIA Autoantibody QTL 4,3.1,,blood autoantibody amount (VT:0003725),calculated serum anti-rat type 2 collagen autoantibody titer (CMO:0001281),4,125884464,168047091,Rat,n/a,region,qtl 1000,70216,Cm14,Cardiac mass QTL 14,2.1,,heart mass (VT:0007028),heart wet weight (CMO:0000069),3,30846101,172879276,Rat,n/a,region,qtl 1000,724532,Cm17,Cardiac mass QTL 17,2,,heart mass (VT:0007028),calculated heart weight (CMO:0000073),3,101058963,146058963,Rat,n/a,region,qtl 1000,724535,Cm18,Cardiac mass QTL 18,2.6,,heart mass (VT:0007028),calculated heart weight (CMO:0000073),4,117926139,162926139,Rat,n/a,region,qtl 1000,1581503,Cm58,Cardiac mass QTL 58,2.7,0.05,heart left ventricle mass (VT:0007031),heart left ventricle weight to body weight ratio (CMO:0000530),3,45406058,127023997,Rat,n/a,region,qtl 1000,2301971,Cm71,Cardiac mass QTL 71,4.63,,heart left ventricle mass (VT:0007031),heart left ventricle weight (CMO:0000776),3,43295930,163640485,Rat,n/a,region,qtl 1000,1354611,Despr2,Despair related QTL 2,3.03,0.0028,locomotor behavior trait (VT:0001392),amount of time spent in voluntary immobility (CMO:0001043),3,102466149,147466149,Rat,n/a,region,qtl 1000,1559282,Emca5,Estrogen-induced mammary cancer QTL 5,3.9,,mammary gland integrity trait (VT:0010552),percentage of study population developing mammary tumors during a period of time (CMO:0000948),3,45406058,177699992,Rat,n/a,region,qtl 1000,1576305,Emca6,Estrogen-induced mammary cancer QTL 6,5.8,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),4,43414605,155469929,Rat,n/a,region,qtl 1000,1582239,Epfw1,Epididymal fat weight QTL 1,4.5,0.0006,epididymal fat pad mass (VT:0010421),epididymal fat pad weight to body weight ratio (CMO:0000658),3,54630948,119830094,Rat,n/a,region,qtl 1000,2292613,Ept16,Estrogen-induced pituitary tumorigenesis QTL 16,8.3,,pituitary gland mass (VT:0010496),pituitary gland wet weight (CMO:0000853),3,48562146,115249962,Rat,n/a,region,qtl 1000,1358186,Ept2,Estrogen-induced pituitary tumorigenesis QTL 2,8.3,,pituitary gland mass (VT:0010496),pituitary gland wet weight (CMO:0000853),3,48562146,115249962,Rat,n/a,region,qtl 1000,1576316,Ept5,Estrogen-induced pituitary tumorigenesis QTL 5,3.8,,pituitary gland mass (VT:0010496),pituitary gland wet weight (CMO:0000853),4,84475257,178931073,Rat,n/a,region,qtl 1000,2292591,Esta4,Estrogen-induced thymic atrophy QTL 4,,,thymus mass (VT:0004954),thymus wet weight (CMO:0000855),3,48561928,155263151,Rat,n/a,region,qtl 1000,1354612,Foco1,Food consumption QTL 1,8.87,,eating behavior trait (VT:0001431),food intake rate (CMO:0000427),4,43414792,146942075,Rat,n/a,region,qtl 1000,70201,Gcr1,Gastric cancer resistance QTL 1,2.7,,stomach morphology trait (VT:0000470),stomach tumor susceptibility score (CMO:0002043),4,119705414,146087100,Rat,n/a,region,qtl 1000,2312567,Glom19,Glomerulus QTL 19,1.9,0.006,kidney glomerulus morphology trait (VT:0005325),index of glomerular damage (CMO:0001135),4,49906054,145611886,Rat,n/a,region,qtl 1000,1358202,Gluco11,Glucose level QTL 11,2.4,0.02,adipocyte glucose uptake trait (VT:0004185),absolute change in adipocyte glucose uptake (CMO:0000873),4,86438317,168047091,Rat,n/a,region,qtl 1000,1582232,Gluco25,Glucose level QTL 25,3.6,0.0023,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),4,86312589,146942261,Rat,n/a,region,qtl 1000,2302273,Gluco35,Glucose level QTL 35,5.3,0.001,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),3,83817637,119509260,Rat,n/a,region,qtl 1000,2302373,Gluco39,Glucose level QTL 39,5.01,,blood glucose amount (VT:0000188),blood glucose level area under curve (AUC) (CMO:0000350),3,103141944,170934860,Rat,n/a,region,qtl 1000,2316958,Gluco58,Glucose level QTL 58,10,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),4,7850904,182171018,Rat,n/a,region,qtl 1000,737818,Hcar12,Hepatocarcinoma resistance QTL 12,2.6,,liver integrity trait (VT:0010547),volume of individual liver tumorous lesion (CMO:0001078),3,30114912,123700444,Rat,n/a,region,qtl 1000,634347,Hcar8,Hepatocarcinoma resistance QTL 8,5.8,,liver integrity trait (VT:0010547),liver tumorous lesion area to total liver area ratio (CMO:0001075),4,123478354,168478354,Rat,n/a,region,qtl 1000,737821,Hcar9,Hepatocarcinoma resistance QTL 9,3.7,,liver integrity trait (VT:0010547),volume of individual liver tumorous lesion (CMO:0001078),4,105971071,168047091,Rat,n/a,region,qtl 1000,1331759,Hrtrt13,Heart rate QTL 13,3.54628,,heart pumping trait (VT:2000009),heart rate (CMO:0000002),4,108876717,169215811,Rat,n/a,region,qtl 1000,1300116,Hrtrt5,Heart rate QTL 5,3.76,,heart pumping trait (VT:2000009),heart rate (CMO:0000002),4,115372758,150038284,Rat,n/a,region,qtl 1000,631674,Iddm14,Insulin dependent diabetes mellitus QTL 14,,,blood glucose amount (VT:0000188),plasma glucose level (CMO:0000042),4,63537179,157286626,Rat,n/a,region,qtl 1000,2293087,Iddm27,Insulin dependent diabetes mellitus QTL 27,2.68,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),3,102152812,155263151,Rat,n/a,region,qtl 1000,2293840,Kiddil9,Kidney dilation QTL 9,2.9,,kidney pelvis morphology trait (VT:0004194),hydronephrosis severity score (CMO:0001208),4,120400597,146942261,Rat,n/a,region,qtl 1000,1582221,Kidm30,Kidney mass QTL 30,3.5,0.0008,kidney mass (VT:0002707),both kidneys wet weight (CMO:0000085),3,66711607,119830094,Rat,n/a,region,qtl 1000,2301414,Kidm37,Kidney mass QTL 37,,0.001,kidney mass (VT:0002707),both kidneys wet weight to body weight ratio (CMO:0000340),3,72973445,127023997,Rat,n/a,region,qtl 1000,631841,Niddm39,Non-insulin dependent diabetes mellitus QTL 39,3.36,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),3,99465522,168732722,Rat,n/a,region,qtl 1000,61362,Oia2,Oil induced arthritis QTL 2,,0.001,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),4,136351734,174694858,Rat,n/a,region,qtl 1000,1298524,Oia8,Oil induced arthritis QTL 8,,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),4,136351734,174694858,Rat,n/a,region,qtl 1000,737978,Pia23,Pristane induced arthritis QTL 23,5.3,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),4,131532269,168047091,Rat,n/a,region,qtl 1000,2302049,Pia32,Pristane induced arthritis QTL 32,5.1,0.001,blood autoantibody amount (VT:0003725),serum immunoglobulin G-type rheumatoid factor level relative to an arbitrary reference serum (CMO:0002112),4,105277348,150277348,Rat,n/a,region,qtl 1000,631511,Pia7,Pristane induced arthritis QTL 7,4.3,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),4,131532269,168047091,Rat,n/a,region,qtl 1000,724558,Plsm2,Polydactyly-luxate syndrome (PLS) morphotypes QTL 2,,0.0003,hindlimb integrity trait (VT:0010563),hind foot phalanges count (CMO:0001949),4,131834282,176834282,Rat,n/a,region,qtl 1000,1581546,Pur13,Proteinuria QTL 13,2.93,0.0335,total urine protein amount (VT:0000032),urine protein excretion rate (CMO:0000759),3,81136227,154416635,Rat,n/a,region,qtl 1000,1300111,Rf12,Renal function QTL 12,3.78,,renal blood flow trait (VT:2000006),absolute change in renal blood flow rate (CMO:0001168),3,62922868,127023997,Rat,n/a,region,qtl 1000,619618,Rf3,Renal disease susceptibility QTL 3,6.5,0.001,urine albumin amount (VT:0002871),urine albumin excretion rate to body weight ratio (CMO:0001270),3,114376250,159376250,Rat,n/a,region,qtl 1000,1581568,Rf53,Renal function QTL 53,,,total urine protein amount (VT:0000032),urine protein excretion rate to body weight ratio (CMO:0001099),3,58204463,170534769,Rat,n/a,region,qtl 1000,738009,Sach4,Saccharine consumption QTL 4,4.9,0.000016,consumption behavior trait (VT:0002069),saccharin intake volume to total fluid intake volume ratio (CMO:0001601),4,58640017,154427984,Rat,n/a,region,qtl 1000,1354660,Salc1,Saline consumption QTL 1,11.26,,drinking behavior trait (VT:0001422),saline drink intake rate (CMO:0001627),4,43414792,146942075,Rat,n/a,region,qtl 1000,1549827,Scl46,Serum cholesterol level QTL 46,3.5,,blood cholesterol amount (VT:0000180),serum total cholesterol level (CMO:0000363),4,131864442,176864442,Rat,n/a,region,qtl 1000,2312673,Scl63,Serum cholesterol level QTL 63,,0.001,blood cholesterol amount (VT:0000180),serum total cholesterol level (CMO:0000363),3,103141814,176418101,Rat,n/a,region,qtl 1000,61406,Scwia1,Streptococcal cell wall induced arthritis QTL 1,2.3,,joint integrity trait (VT:0010548),experimental arthritis severity measurement (CMO:0001459),4,105682594,150682594,Rat,n/a,region,qtl 1000,2312659,Slep7,Serum leptin concentration QTL 7,,0.001,blood leptin amount (VT:0005667),serum leptin level (CMO:0000780),3,103141814,176418101,Rat,n/a,region,qtl 1000,1358364,Sradr4,Stress Responsive Adrenal Weight QTL 4,4.92,,adrenal gland mass (VT:0010420),both adrenal glands wet weight (CMO:0000164),4,128602727,173602727,Rat,n/a,region,qtl 1000,1358362,Srcrt2,Stress Responsive Cort QTL 2,2.78,,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),3,39248391,140271184,Rat,n/a,region,qtl 1000,1358352,Srcrt3,Stress Responsive Cort QTL 3,2.29,,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),4,36615599,145611886,Rat,n/a,region,qtl 1000,1331802,Srn5,Serum renin concentration QTL 5,3.045,,renin activity (VT:0005581),plasma renin activity level (CMO:0000116),4,116726724,157291438,Rat,n/a,region,qtl 1000,1298082,Stresp4,Stress response QTL 4,,,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),4,46898276,145611886,Rat,n/a,region,qtl 1000,724523,Tsu1,Thymus enlargement suppressive QTL 1,3.84,,thymus mass (VT:0004954),thymus weight to body weight ratio (CMO:0000612),3,51822008,120917851,Rat,n/a,region,qtl 1000,731165,Uae21,Urinary albumin excretion QTL 21,2.4,0.0001,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),4,106347236,151347236,Rat,n/a,region,qtl 1000,2303623,Vencon2,Ventilatory control QTL 2,3.8,,respiration trait (VT:0001943),minute ventilation (VE) (CMO:0000132),4,134917642,179917642,Rat,n/a,region,qtl 1000,8662816,Vetf4,Vascular elastic tissue fragility QTL 4,4,,renal artery integrity trait (VT:0010642),number of ruptures of the internal elastic lamina of the renal arteries (CMO:0002563),3,61241033,165369047,Rat,n/a,region,qtl 1000,70177,Xhs1,X-ray hypersensitivity QTL 1,25.1,,intestine integrity trait (VT:0010554),post-insult time to onset of moribundity (CMO:0001896),4,81959983,152055009,Rat,n/a,region,qtl